Addis & Hill, Inc NMRA — NEUMORA THERAPEUTICS INC.

Ownership history in Addis & Hill, Inc  ·  9 quarters on record

AI Ownership Summary

Addis & Hill, Inc reported NEUMORA THERAPEUTICS INC. (NMRA) in 9 quarterly 13F filings from 2024 Q1 through 2026 Q1. Peak portfolio weight reached 3.57% in 2024 Q1. The latest visible filing shows NMRA at 0.19% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this NMRA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Addis & Hill, Inc's position in NEUMORA THERAPEUTICS INC., and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

NMRA was reported at 0.19% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
3.57% in 2024 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

NMRA stock page Addis & Hill, Inc fund profile Addis & Hill, Inc full holdings
How Addis & Hill, Inc held NMRA — position size vs. price
% of Fund (quarterly)    NMRA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 163,386 — 0% 0.19% $319K 2026-04-16 $2.00
2025 Q4 UNCHANGED — — — 163,386 — 0% 0.18% $292K 2026-01-06 $1.82
2025 Q3 UNCHANGED — — — 163,386 — 0% 0.18% $291K 2025-10-17 $1.73
2025 Q2 UNCHANGED — — — 163,386 — 0% 0.08% $120K 2025-07-11 $1.29
2025 Q1 UNCHANGED — — — 163,386 — 0% 0.11% $163K 2025-04-10 $0.72
2024 Q4 REDUCED 45.5% -90.6% ✅ 163,386 -136,614 -45.5% 1.28% $1.7M 2025-01-31 $1.93
2024 Q3 UNCHANGED — — — 300,000 — 0% 3.04% $4.0M 2024-10-28 $11.85
2024 Q2 REDUCED — — — 300,000 -14,821 -4.7% 2.45% $2.9M 2024-07-18 $10.99
2024 Q1 INITIATED — — — 314,821 — — 3.57% $4.2M 2024-04-23 $10.30

🏢 Other funds also holding NMRA

As of 2026 Q1 — sorted by position size

Lunate Capital Ltd 3.44% MIC Capital Management UK LLP 3Y 2.47% JOHNSON & JOHNSON 3Y 0.55% Siren, L.L.C. 0.46% Stonepine Capital Management, LLC 3Y 7Y 0.39% Ikarian Capital, LLC 3Y 0.2% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.19% SILVERARC CAPITAL MANAGEMENT, LLC 3Y 0.16% ICONIQ Capital, LLC 3Y 7Y 0.11% SOFTBANK GROUP CORP. 3Y 0.1%

FAQ About Addis & Hill, Inc and NMRA

These are the practical questions this page is built to answer before you even open the full history table.

How long has Addis & Hill, Inc reported owning NMRA?

Addis & Hill, Inc reported NMRA across 9 quarterly 13F filings, from 2024 Q1 through 2026 Q1.

What was the largest reported NMRA position in Addis & Hill, Inc's portfolio?

The largest reported portfolio weight for NMRA was 3.57% in 2024 Q1.

What is the latest reported NMRA position on this page?

The most recent filing on this page is 2026 Q1, when Addis & Hill, Inc reported 163,386 shares, equal to 0.19% of portfolio, with an estimated market value of $319K.

What does the chart on this NMRA ownership page compare?

The chart compares Addis & Hill, Inc's quarterly NMRA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Addis & Hill, Inc time their NMRA position?

Based on 13F filing dates vs. subsequent NMRA price moves, Addis & Hill, Inc correctly timed 2 out of 3 reported position changes (67%). The annualised alpha on NMRA relative to SPY over the holding period was -62.1%.

← Back to Addis & Hill, Inc Holdings